Verona Pharma Plc Net Tangible Assets

Verona Pharma Plc (VRNA) currently reports a net tangible assets of $280M as of June 2025. That compares with $170M in the prior-year period — up 65.4% year over year. Use the charts on this page to explore Verona Pharma Plc's net tangible assets history and peer comparisons.

Verona Pharma Plc's net tangible assets increased from $170M to $280M — a 65.4% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Verona Pharma Plc reported $280M in net tangible assets as of June 2025. That compares with $170M in the prior-year period — up 65.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $280M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Verona Pharma Plc, and consider following VRNA for alerts when major investors trade the stock.

Verona Pharma Plc is classified in the Healthcare sector. On net tangible assets, it currently shows $280M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VRNA with unrelated industries.